Reductions seen in mean office sitting systolic BP and sitting diastolic BP and in mean 24-hour ambulatory systolic BP
WEDNESDAY, Sept. 11, 2024 (HealthDay News) — For patients with resistant hypertension, a quadruple single pill is superior to triple therapy, according to a study presented at the European Society of Cardiology Congress, held from Aug. 30 to Sept. 2 in London.
Stefano Taddei, from the University of Pisa in Italy, and colleagues conducted a double-blind, randomized trial involving patients with resistant hypertension. Participants completed an eight-week run-in period during which they received the triple combination of perindopril, indapamide, and amlodipine. Those with uncontrolled blood pressure (BP) after eight weeks while adherent to therapy were randomly allocated to continue the same triple therapy or receive a single-pill combination containing perindopril, indapamide, amlodipine, and bisoprolol. A total of 183 patients from 49 centers in 13 countries were included in the trial.
The researchers found that the mean office sitting systolic BP was reduced by 20.67 and 11.32 mm Hg in the quadruple single-pill group and in the triple group, respectively, after eight weeks, with the adjusted difference significant in favor of the quadruple single pill. For the main secondary end point of mean 24-hour ambulatory systolic BP, there was a significant difference for the quadruple single pill versus the triple group (−7.53 mm Hg); in addition, there was a significant difference in favor of the quadruple single-pill group in mean office sitting diastolic BP (−6.14 mm Hg). BP control was achieved by 66.3 and 42.7 percent on the quadruple single pill and on triple therapy, respectively.
“The availability of a quadruple single-pill combination that includes bisoprolol could help with non-adherence and provide much-needed effective BP control in patients with resistant or difficult-to-treat hypertension,” Taddei said in a statement.
Several authors disclosed ties to the pharmaceutical and medical device industry, including Servier, which funded the study.
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL 
Mortality in Injured Children Linked to Higher SBP Thresholds Than Those That Define Hypotension 
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors 
Eating More Whole Grains Daily Linked to Cardiometabolic Benefits 
Intensive BP Lowering Reduces Recurrent Stroke After Intracerebral Hemorrhage 
Onset of Mortality, Morbidity Delayed for Offspring of Centenarians 
Vascular Burden in Midlife Linked to Increased Risk for Dementia, Death 
28 Percent of U.S. Adults With HTN Eligible for Treatment Under New Guidelines 
